{"id":384628,"date":"2023-10-19T07:01:25","date_gmt":"2023-10-19T07:01:25","guid":{"rendered":"https:\/\/haftavasool.com\/haftavasool\/blog\/2023\/10\/19\/who-outlines-considerations-for-regulation-of-artificial-intelligence-for-health\/"},"modified":"2023-10-19T07:01:25","modified_gmt":"2023-10-19T07:01:25","slug":"who-outlines-considerations-for-regulation-of-artificial-intelligence-for-health","status":"publish","type":"post","link":"https:\/\/haftavasool.com\/haftavasool\/blog\/2023\/10\/19\/who-outlines-considerations-for-regulation-of-artificial-intelligence-for-health\/","title":{"rendered":"WHO outlines considerations for regulation of artificial intelligence for health"},"content":{"rendered":"<p> [ad_1]<br \/>\n<\/p>\n<div>\n<p>The World Health Organization (WHO) has released a new publication listing key regulatory considerations on artificial intelligence (AI) for health. The publication emphasizes the importance of establishing AI systems\u2019 safety and effectiveness, rapidly making appropriate systems available to those who need them, and fostering dialogue among stakeholders, including developers, regulators, manufacturers, health workers, and patients.<strong><em><span style=\"text-decoration:underline;\"\/><\/em><\/strong><\/p>\n<p>With the increasing availability of health care data and the rapid progress in analytic techniques \u2013 whether machine learning, logic-based or statistical \u2013 AI tools could transform the health sector. WHO recognizes the potential of AI in enhancing health outcomes by strengthening clinical trials; improving medical diagnosis, treatment, self-care and person-centred care; and supplementing health care professionals\u2019 knowledge, skills and competencies. For example, AI could be beneficial in settings with a lack of medical specialists, e.g. in interpreting retinal scans and radiology images among many others.<\/p>\n<p>However, AI technologies \u2013 including large language models \u2013 are being rapidly deployed, sometimes without a full understanding of how they may perform, which could either benefit or harm end-users, including health-care professionals and patients. When using health data, AI systems could have access to sensitive personal information, necessitating robust legal and regulatory frameworks for safeguarding privacy, security, and integrity, which this publication aims to help set up and maintain.<\/p>\n<p>\u201cArtificial intelligence holds great promise for health, but also comes with serious challenges, including unethical data collection, cybersecurity threats and amplifying biases or misinformation,\u201d said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. \u201cThis new guidance will support countries to regulate AI effectively, to harness its potential, whether in treating cancer or detecting tuberculosis, while minimising the risks.\u201d\u00a0<\/p>\n<p>In response to growing country needs to responsibly manage the rapid rise of AI health technologies, the publication outlines six areas for regulation of AI for health.<\/p>\n<ul>\n<li>To foster trust, the publication stresses the importance of <strong>transparency and documentation<\/strong>, such as through documenting the entire product lifecycle and tracking development processes.<\/li>\n<li>For <strong>risk management<\/strong>, issues like \u2018intended use\u2019, \u2018continuous learning\u2019, human interventions, training models and cybersecurity threats must all be comprehensively addressed, with models made as simple as possible.<\/li>\n<li>Externally <strong>validating data<\/strong> and being clear about the <strong>intended use <\/strong>of AI helps assure safety and facilitate regulation.<\/li>\n<li>A commitment to <strong>data quality<\/strong>, such as through rigorously evaluating systems pre-release, is vital to ensuring systems do not amplify biases and errors.<\/li>\n<li>The challenges posed by important, complex regulations \u2013 such as the General Data Protection Regulation (GDPR) in Europe and the Health Insurance Portability and Accountability Act (HIPAA) in the United States of America \u2013 are addressed with an emphasis on understanding the scope of jurisdiction and consent requirements, in service of <strong>privacy and data protection.<\/strong><\/li>\n<li>Fostering <strong>collaboration <\/strong>between regulatory bodies, patients, healthcare professionals, industry representatives, and government partners, can help ensure products and services stay compliant with regulation throughout their lifecycles.<\/li>\n<\/ul>\n<p>AI systems are complex and depend not only on the code they are built with but also on the data they are trained on, which come from clinical settings and user interactions \u2013 for example. Better regulation can help manage the risks of AI amplifying biases in training data.\u00a0<\/p>\n<p>For example, it can\u00a0be difficult for AI models to accurately represent the diversity of populations, leading to biases, inaccuracies or even failure.\u00a0To help mitigate these risks, regulations can be used to ensure that the\u00a0attributes \u2013 such as gender, race and ethnicity \u2013 of the people featured in the training data are reported and datasets are intentionally made representative.\u00a0<\/p>\n<p>The new WHO publication aims to outline key principles that governments and regulatory authorities can follow to develop new guidance or adapt existing guidance on AI at national or regional levels. \u00a0<\/p>\n<\/div>\n<p>[ad_2]<br \/>\n<br \/><a href=\"https:\/\/www.who.int\/news\/item\/19-10-2023-who-outlines-considerations-for-regulation-of-artificial-intelligence-for-health\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>[ad_1] The World Health Organization (WHO) has released a new publication listing key regulatory considerations on artificial intelligence (AI) for health. The publication emphasizes the importance of establishing AI systems\u2019 safety and effectiveness, rapidly making appropriate systems available to those who need them, and fostering dialogue among stakeholders, including developers, regulators, manufacturers, health workers, and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":384629,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21],"tags":[],"_links":{"self":[{"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/posts\/384628"}],"collection":[{"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/comments?post=384628"}],"version-history":[{"count":0,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/posts\/384628\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/media\/384629"}],"wp:attachment":[{"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/media?parent=384628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/categories?post=384628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haftavasool.com\/haftavasool\/wp-json\/wp\/v2\/tags?post=384628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}